We use cookies to help us improve the website and your experience using it. You may delete and block all cookies from this site at any time. However, please note this may result in parts of the site no longer working correctly. If you continue without changing your settings we will assume you are happy to receive all cookies on this site.


Myeloproliferative Disorders

In 2005, the JAK2 V617F mutation was found in almost all patients with PV and about half of those patients with ET and IMF.

This test is now part of the clinical work up guidelines for diagnosing these patients.

For JAK2 molecular tests, 10ml EDTA PB is required and not a BM aspirate sample.


(Last reviewed 12th February 2018)